Physician profile
Jaenelle Ignacio
NPI 1700564028
$2,039.70
in general payments reported to CMS, 2019-2025
8 companies · $1,293 in 2025
The $1,293 reported for 2025 was more than what 96% of Critical Care Medicine (Registered Nurse) providers received nationally (typical 2025 total: $51.32).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $73.62 · 2024: $673 · 2025: $1,293.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,458 · Travel and Lodging: $581.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,458.35 |
| Travel and Lodging | $581.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $1,183.48 | 2023-2025 | Iovera, Exparel, Zilretta |
| Pfizer INC. | $240.40 | 2024-2025 | |
| Abbvie INC. | $233.15 | 2024-2025 | |
| Painteq LLC | $156.79 | 2025 | Painteq |
| Collegium Pharmaceutical, INC. | $125.22 | 2023-2025 | Belbuca, Xtampza |
| Electronic Waveform Lab, INC. | $57.12 | 2024-2025 | |
| Vertex Pharmaceuticals Incorporated | $29.35 | 2025 | |
| Curonix LLC | $14.19 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaenelle Ignacio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.